Peptron Inc Market Cap ($958.68 Million)
Market Cap & Net Worth: Peptron Inc (087010)
Peptron Inc market cap. Peptron Inc (KQ:087010) has a market capitalization of $958.68 Million (₩1.41 Trillion) as of November 1, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #8734 globally and #224 in its home market, demonstrating a -9.78% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Peptron Inc's stock price ₩92300.00 by its total outstanding shares 15326500 (15.33 Million). Also see 087010 cash flow conversion for how efficiently the company converts equity into cash flow.
Peptron Inc Market Cap History (2015–2026)
Peptron Inc market cap history from 2015 to 2026. Data shows growth from $333.00 Million to $958.68 Million (15.10% CAGR). Check Peptron Inc (087010) stock price for real-time trading data and today's change.
Index Memberships
Peptron Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$208.91 Billion | 0.46% | #44 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$208.91 Billion | 0.46% | #44 of 1384 |
Weight: Peptron Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Peptron Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Peptron Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 087010 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.47x
Peptron Inc's market cap is 0.47 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $193.14 Million | $3.13 Billion | -$3.19 Billion | 0.06x | N/A |
| 2017 | $325.60 Million | $3.22 Billion | -$4.43 Billion | 0.10x | N/A |
| 2018 | $240.74 Million | $3.86 Billion | -$3.73 Billion | 0.06x | N/A |
| 2019 | $192.89 Million | $1.80 Billion | -$17.72 Billion | 0.11x | N/A |
| 2020 | $170.34 Million | $3.12 Billion | -$18.38 Billion | 0.05x | N/A |
| 2021 | $115.29 Million | $6.62 Billion | -$15.04 Billion | 0.02x | N/A |
| 2022 | $79.46 Million | $5.81 Billion | -$15.06 Billion | 0.01x | N/A |
| 2023 | $418.06 Million | $3.34 Billion | -$15.92 Billion | 0.13x | N/A |
| 2024 | $1.06 Billion | $3.15 Billion | -$22.03 Billion | 0.34x | N/A |
| 2025 | $2.64 Billion | $5.63 Billion | -$13.82 Billion | 0.47x | N/A |
Competitor Companies of 087010 by Market Capitalization
Companies near Peptron Inc in the global market cap rankings as of November 1, 2026. Also see 087010 total asset value for a full breakdown of the balance sheet.
Key companies related to Peptron Inc by market ranking:
- Bioneer Corporation (KQ:064550): Ranked #18937 globally with a market cap of $101.98 Million USD ( ₩150.48 Billion KRW).
- MEDIPOST Co. Ltd (KQ:078160): Ranked #19665 globally with a market cap of $84.32 Million USD ( ₩124.42 Billion KRW).
- Cell Biotech Co. Ltd (KQ:049960): Ranked #20019 globally with a market cap of $77.43 Million USD ( ₩114.26 Billion KRW).
- Macrogen Inc (KQ:038290): Ranked #20204 globally with a market cap of $74.03 Million USD ( ₩109.23 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #18937 | Bioneer Corporation | KQ:064550 | $101.98 Million | ₩6810.00 |
| #19665 | MEDIPOST Co. Ltd | KQ:078160 | $84.32 Million | ₩8090.00 |
| #20019 | Cell Biotech Co. Ltd | KQ:049960 | $77.43 Million | ₩14800.00 |
| #20204 | Macrogen Inc | KQ:038290 | $74.03 Million | ₩10900.00 |
Market Capitalization of Peptron Inc (2015–2026)
Market capitalization of Peptron Inc from 2015 to today. Between 2015 and today, Peptron Inc's market cap moved from $333.00 Million to $ 958.68 Million, with a yearly change of 15.10%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩958.68 Million | -63.66% |
| 2025 | ₩2.64 Billion | +149.51% |
| 2024 | ₩1.06 Billion | +152.92% |
| 2023 | ₩418.06 Million | +426.14% |
| 2022 | ₩79.46 Million | -31.08% |
| 2021 | ₩115.29 Million | -32.32% |
| 2020 | ₩170.34 Million | -11.69% |
| 2019 | ₩192.89 Million | -19.88% |
| 2018 | ₩240.74 Million | -26.06% |
| 2017 | ₩325.60 Million | +68.58% |
| 2016 | ₩193.14 Million | -42.00% |
| 2015 | ₩333.00 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Peptron Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $958.68 Million USD |
| MoneyControl | $958.68 Million USD |
| MarketWatch | $958.68 Million USD |
| marketcap.company | $958.68 Million USD |
| Reuters | $958.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Peptron Inc
Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, premenopausal breast cancer, … Read more